Insider Selling: Heartflow (NASDAQ:HTFL) Insider Sells $1,316,554.33 in Stock

Heartflow, Inc. (NASDAQ:HTFL) insider Campbell Rogers sold 23,933 shares of the business’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total value of $1,316,554.33. Following the completion of the transaction, the insider directly owned 73,453 shares in the company, valued at $4,040,649.53. This represents a 24.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

• On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $987,052.30.
• On Monday, August 17th, Campbell Rogers sold 9,219 shares of Heartflow stock. The stock was sold at an average price of $41.23, for a total value of $380,099.37.

Heartflow Price Performance

NASDAQ HTFL opened at $59.10 on Thursday. The stock has a market capitalization of $5.14 billion, a P/E ratio of -32.30 and a beta of 2.73. The business has a 50 day simple moving average of $50.28 and a 200 day simple moving average of $33.89. Heartflow, Inc. has a one year low of $20.13 and a one year high of $60.29.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. Heartflow’s revenue was up 47.7% compared to the same quarter last year. Equities analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HTFL shares. Stifel Nicolaus boosted their target price on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Canaccord Genuity Group raised their price target on shares of Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a report on Tuesday, September 22nd. Wall Street Zen raised shares of Heartflow from a “hold” rating to a “buy” rating in a research note on Sunday. Wells Fargo & Company lifted their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Finally, Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Heartflow currently has an average rating of “Moderate Buy” and a consensus price target of $48.62.

Institutional Investors Weigh In On Heartflow

Hedge funds have recently added to or reduced their stakes in the company. Sterling Capital Management LLC grew its holdings in shares of Heartflow by 797.9% during the third quarter. Sterling Capital Management LLC now owns 2,532 shares of the company’s stock valued at $126,000 after buying an additional 2,250 shares during the last quarter. Crescent Grove Advisors LLC acquired a new stake in shares of Heartflow in the 3rd quarter worth about $249,000. IFP Advisors Inc raised its holdings in shares of Heartflow by 844.7% in the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company’s stock worth $40,000 after acquiring an additional 718 shares during the last quarter. Vontobel Holding Ltd. bought a new position in Heartflow in the 3rd quarter valued at about $1,020,000. Finally, Avior Wealth Management LLC lifted its position in Heartflow by 16.1% in the 3rd quarter. Avior Wealth Management LLC now owns 14,553 shares of the company’s stock valued at $724,000 after acquiring an additional 2,023 shares in the last quarter.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.